Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study.


Journal

The European journal of neuroscience
ISSN: 1460-9568
Titre abrégé: Eur J Neurosci
Pays: France
ID NLM: 8918110

Informations de publication

Date de publication:
11 2022
Historique:
revised: 16 05 2022
received: 31 10 2021
accepted: 04 06 2022
pubmed: 10 6 2022
medline: 16 11 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Epilepsy is increasing, being more common in older adults, with more than 20% of late-onset cases with unknown aetiology (LOEU). Although epilepsy was associated with cognitive impairment, few studies evaluated the trajectories of cognitive decline in patients with LOEU. The present study aimed at assessing biomarkers of Alzheimer's disease (AD) in patients with LOEU and evaluating their cognitive performance for 12 months. For this study, 55 patients diagnosed with LOEU and 21 controls were included. Participants underwent cognitive evaluation and cerebrospinal fluid (CSF) biomarker analysis (ß-amyloid

Identifiants

pubmed: 35678770
doi: 10.1111/ejn.15734
doi:

Substances chimiques

tau Proteins 0
Amyloid beta-Peptides 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Biomarkers 0
Glucose IY9XDZ35W2
Peptide Fragments 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5384-5396

Informations de copyright

© 2022 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Références

Baker, G. A., Taylor, J., & Aldenkamp, A. P. (2011). Newly diagnosed epilepsy: Cognitive outcome after 12 months. Epilepsia, 52(6), 1084-1091. https://doi.org/10.1111/j.1528-1167.2011.03043.x
Beghi, E., & Giussani, G. (2018). Aging and the epidemiology of epilepsy. Neuroepidemiology, 51(3-4), 216-223. https://doi.org/10.1159/000493484
Bennett, C. M., Wolford, G. L., & Miller, M. B. (2009). The principled control of false positives in neuroimaging. Social Cognitive and Affective Neuroscience, 4, 417-422. https://doi.org/10.1093/scan/nsp053
Caffarra, P., Vezzadini, G., Dieci, F., Zonato, F., & Venneri, A. (2002). Rey-Osterrieth complex figure: Normative values in an Italian population sample. Neurological Sciences, 22(6), 443-447. https://doi.org/10.1007/s100720200003
Carlesimo, G. A., Caltagirone, C., Gainotti, G., Fadda, L., Gallassi, R., Lorusso, S., Marfia, G., Marra, C., Nocentini, U., & Parnetti, L. (1996). The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. European Neurology, 36(6), 378-384. https://doi.org/10.1159/000117297
Chiaravalloti, A., Barbagallo, G., Martorana, A., Castellano, A. E., Ursini, F., & Schillaci, O. (2019). Brain metabolic patterns in patients with suspected non-Alzheimers pathophysiology (SNAP) and Alzheimers disease (AD): Is [18F] FDG a specific biomarker in these patients? European Journal of Nuclear Medicine and Molecular Imaging, 46, 1796-1805. https://doi.org/10.1007/s00259-019-04379-4
Cloyd, J., Hauser, W., Towne, A., Ramsay, R., Mattson, R., Gilliam, F., & Walczak, T. (2006). Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Research, 68, 39-48. https://doi.org/10.1016/j.eplepsyres.2005.07.016
Costa, C., Parnetti, L., DAmelio, M., Tozzi, A., Tantucci, M., Romigi, A., Siliquini, S., Cavallucci, V., Di Filippo, M., Mazzocchetti, P., Liguori, C., Nobili, A., Eusebi, P., Mercuri, N. B., & Calabresi, P. (2016). Epilepsy, amyloid-β, and D1 dopamine receptors: A possible pathogenetic link? Neurobiology of Aging, 48, 161-171. https://doi.org/10.1016/j.neurobiolaging.2016.08.025
Costa, C., Romoli, M., & Calabresi, P. (2018). Late onset epilepsy and Alzheimers disease: Exploring the dual pathogenic role of amyloid-b. Brain, 141(8), e60. https://doi.org/10.1093/brain/awy162
Costa, C., Romoli, M., Liguori, C., Farotti, L., Eusebi, P., Bedetti, C., Siliquini, S., Cesarini, E. N., Romigi, A., Mercuri, N. B., Parnetti, L., & Calabresi, P. (2019). Alzheimers disease and late-onset epilepsy of unknown origin: Two faces of beta amyloid pathology. Neurobiology of Aging, 73, 61-67. https://doi.org/10.1016/j.neurobiolaging.2018.09.006
DAgostino, E., Maes, F., Vandermeulen, D., & Suetens, P. (2007). Atlas-to-image non-rigid registration by minimization of conditional local entropy. Information Processing in Medical Imaging, 20, 320-332.
Dickstein, L. P., Liow, J., Austermuehle, A., Zoghbi, S., Inati, S. K., Zaghloul, K., Zanotti-Fregonara, P., & Theodore, W. H. (2019). Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein. Epilepsia, 60, 1248-1254. https://doi.org/10.1111/epi.15967
DiFrancesco, J. C., Isella, V., Licciardo, D., Crivellaro, C., Musarra, M., Guerra, L., Salvadori, N., Chipi, E., Calvello, C., Costa, C., & Ferrarese, C. (2021). Temporal lobe dysfunction in late-onset epilepsy of unknown origin. Epilepsy & Behavior, 117, 107839. https://doi.org/10.1016/j.yebeh.2021.107839
Duits, F. H., Teunissen, C. E., Bouwman, F. H., Visser, P. J., Mattsson, N., Zetterberg, H., Blennow, K., Hansson, O., Minthon, L., Andreasen, N., Marcusson, J., Wallin, A., Rikkert, M. O., Tsolaki, M., Parnetti, L., Herukka, S. K., Hampel, H., De Leon, M. J., Schröder, J., … Van Der Flier, W. M. (2014). The cerebrospinal fluid “alzheimer profile”: Easily said, but what does it mean? Alzheimer's & Dementia, 10(6), 713, e2-723. https://doi.org/10.1016/j.jalz.2013.12.023
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., DeKosky, S. T., Morris, J. C., & Holtzman, D. M. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta;42 in humans. Annals of Neurology, 59, 512-519. https://doi.org/10.1002/ana.20730
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state (MMSE). Journal of Psychiatric Research, 12(3), 189-198. https://doi.org/10.1016/0022-3956(75)90026-6
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993). Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia, 34, 453-458. https://doi.org/10.1111/j.1528-1157.1993.tb02586.x
He, W., Goodkind, D., & Kowal, P. (2016). An Aging World: 2015 International Population Reports, Aging.
Helmstaedter, C., & Witt, J.-A. (2017). Epilepsy and cognition-a bidirectional relationship? Seizure, 49, 83-89. https://doi.org/10.1016/j.seizure.2017.02.017
Hernández-Ronquillo, L., Adams, S., Ballendine, S., & Téllez-Zenteno, J. F. (2018). Epilepsy in an elderly population: Classification, etiology and drug resistance. Epilepsy Research, 140, 90-94. https://doi.org/10.1016/j.eplepsyres.2017.12.016
Hussain, S. A., Haut, S. R., Lipton, R. B., Derby, C., Markowitz, S. Y., & Shinnar, S. (2006). Incidence of epilepsy in a racially diverse, community-dwelling, elderly cohort: Results from the Einstein aging study. Epilepsy Research, 71(2-3), 195-205. https://doi.org/10.1016/j.eplepsyres.2006.06.018
IBM. (2020). SPSS - Statistical Package for Social Sciences.
World Medical Association. (2013). World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310, 2191-2194. https://doi.org/10.1001/jama.2013.281053
Lancaster, J. L., Rainey, L. H., Summerlin, J. L., Freitas, C. S., Fox, P. T., Evans, A. C., Toga, A. W., & Mazziotta, J. C. (1997). Automated labeling of the human brain: A preliminary report on the development and evaluation of a forward-transform method. Human Brain Mapping, 5(4), 238-242. https://doi.org/10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4
Larner, A. J. (2010). Epileptic seizures in AD patients. Neuromolecular Medicine, 12, 71-77. https://doi.org/10.1007/s12017-009-8076-z
Liguori, C., Chiaravalloti, A., Sancesario, G., Stefani, A., Sancesario, G. M., Mercuri, N. B., Schillaci, O., & Pierantozzi, M. (2016). Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimers disease. European Journal of Nuclear Medicine and Molecular Imaging, 43, 2040-2049. https://doi.org/10.1007/s00259-016-3417-2
Liguori, C., Costa, C., Franchini, F., Izzi, F., Spanetta, M., Cesarini, E. N., Di Santo, S., Manfredi, N., Farotti, L., Romoli, M., Lanari, A., Salvadori, N., Parnetti, L., Calabresi, P., Mercuri, N. B., & Placidi, F. (2019a). Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study. Epilepsy & Behavior, 101, 106592. https://doi.org/10.1016/j.yebeh.2019.106592
Liguori, C., Mercuri, N. B., Nuccetelli, M., Izzi, F., Cordella, A., Bernardini, S., & Placidi, F. (2019b). Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: Is it a further proof for Alzheimers disease risk? Sleep Medicine, 56, 171-176. https://doi.org/10.1016/j.sleep.2019.01.003
Liguori, C., Spanetta, M., Izzi, F., Franchini, F., Nuccetelli, M., Sancesario, G. M., Di Santo, S., Bernardini, S., Mercuri, N. B., & Placidi, F. (2020). Sleep-wake cycle in Alzheimers disease is associated with tau pathology and orexin dysregulation. Journal of Alzheimer's Disease, 74, 501-508. https://doi.org/10.3233/JAD-191124
Liguori, C., Spanetta, M., Romoli, M., Placidi, F., Nardi, E., Biagio, N., & Costa, C. (2021). Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy. Mechanisms of Ageing and Development, 194, 111434. https://doi.org/10.1016/j.mad.2021.111434
Margolis, J. M., Chu, B. L., Wang, Z. J., Copher, R., & Cavazos, J. E. (2014). Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action. JAMA Neurology, 71, 985-993. https://doi.org/10.1001/jamaneurol.2014.808
Mazziotta, J., Toga, A., Evans, A., Fox, P., Lancaster, J., Zilles, K., Woods, R., Paus, T., Simpson, G., Pike, B., Holmes, C., Collins, L., Thompson, P., MacDonald, D., Iacoboni, M., Schormann, T., Amunts, K., Palomero-Gallagher, N., Geyer, S., … Mazoyer, B. (2001). A four-dimensional probabilistic atlas of the human brain. Journal of the American Medical Informatics Association, 8, 401-430. https://doi.org/10.1136/jamia.2001.0080401
Mazziotta, J. C., Toga, A. W., Evans, A., Fox, P., & Lancaster, J. (1995). A probabilistic atlas of the human brain: Theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). NeuroImage, 2, 89-101. https://doi.org/10.1006/nimg.1995.1012
Mulder, C., Verwey, N. A., Van Der Flier, W. M., Bouwman, F. H., Kok, A., Van Elk, E. J., Scheltens, P., & Blankenstein, M. A. (2010). Amyloid-β(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clinical Chemistry, 56, 248-253. https://doi.org/10.1373/clinchem.2009.130518
Nardi Cesarini, E., Babiloni, C., Salvadori, N., Farotti, L., Del Percio, C., Pascarelli, M. T., Noce, G., Lizio, R., Da Re, F., Isella, V., Tremolizzo, L., Romoli, M., DiFrancesco, J. C., Parnetti, L., & Costa, C. (2020). Late-onset epilepsy with unknown etiology: A pilot study on neuropsychological profile, cerebrospinal fluid biomarkers, and quantitative EEG characteristics. Frontiers in Neurology, 11, 1-11. https://doi.org/10.3389/fneur.2020.00199
Osterreith, P. A. (1944). Le test de copie dune figure complexe [A test regarding a complex figure]. Archiv für Psychologie, 30, 206-356.
Ramsay, R. E., Rowan, A. J., & Pryor, F. M. (2004). Special considerations in treating the elderly patient with epilepsy. Neurology, 62(Issue 5, Supplement 2), S24 LP-S29. https://doi.org/10.1212/WNL.62.5_suppl_2.S24
Rey, A. (1964). LExamin Clinique En Psychologie. Universitaire de France.
Sancesario, G. M., Esposito, Z., Nuccetelli, M., Bernardini, S., Sorge, R., Martorana, A., Federici, G., Bernardi, G., & Sancesario, G. (2010). Aβ1-42 detection in CSF of Alzheimers disease is influenced by temperature: Indication of reversible Aβ1-42 aggregation? Experimental Neurology, 223, 371-376. https://doi.org/10.1016/j.expneurol.2009.07.028
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Solomon, L., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., … Zuberi, S. M. (2017). ILAE classification of the epilepsies position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512-521. https://doi.org/10.1111/epi.13709
Sen, A., Capelli, V., & Husain, M. (2018). Cognition and dementia in older patients with epilepsy. Brain, 141(6), 1592-1608. https://doi.org/10.1093/brain/awy022
Stefan, H., May, T. W., Pfäfflin, M., Brandt, C., Füratsch, N., Schmitz, B., Wandschneider, B., Kretz, R., Runge, U., Geithner, J., Karakizlis, C., Rosenow, F., & Kerling, F. (2014). Epilepsy in the elderly: Comparing clinical characteristics with younger patients. Acta Neurologica Scandinavica, 129, 283-293. https://doi.org/10.1111/ane.12218
Tanaka, A., Akamatsu, N., Shouzaki, T., Toyota, T., Yamano, M., Nakagawa, M., & Tsuji, S. (2013). Clinical characteristics and treatment responses in new-onset epilepsy in the elderly. Seizure, 22(9), 772-775. https://doi.org/10.1016/j.seizure.2013.06.005
Wilson, S. J., Baxendale, S., Barr, W., Hamed, S., Langfitt, J., Samson, S., Watanabe, M., Baker, G. A., Helmstaedter, C., & Hermann, B. P. (2015). Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE neuropsychology task force, diagnostic methods commission, 2013-2017. Epilepsia, 56, 674-681. https://doi.org/10.1111/epi.12962
Witt, J. A., Werhahn, K. J., Krämer, G., Ruckes, C., Trinka, E., & Helmstaedter, C. (2014). Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment. Acta Neurologica Scandinavica, 130, 172-177. https://doi.org/10.1111/ane.12260

Auteurs

Mariana Fernandes (M)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Natalia Manfredi (N)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Lavinia Aluisantonio (L)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Flaminia Franchini (F)

IRCCS Fondazione Santa Lucia, Rome, Italy.

Agostino Chiaravalloti (A)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
IRCCS Neuromed, Pozzilli, Italy.

Francesca Izzi (F)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Simona Di Santo (S)

IRCCS Fondazione Santa Lucia, Rome, Italy.

Orazio Schillaci (O)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
IRCCS Neuromed, Pozzilli, Italy.

Nicola Biagio Mercuri (NB)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
IRCCS Fondazione Santa Lucia, Rome, Italy.

Fabio Placidi (F)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Claudio Liguori (C)

Epilepsy Centre, Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH